aibio
Debt Financing ·
Idorsia takes up to CHF 250 million senior secured term loan
The first CHF 150 million tranche will refinance the existing New Money Facility, of which CHF 105 million has been drawn.
IDIA Idorsia Ltd.
Idorsia (IDIA) news
Latest Idorsia news
We have not published a story on Idorsia yet. When there is news, it will appear here.
Questions about Idorsia
What is the ticker symbol of Idorsia?
Idorsia Ltd. trades under the ticker IDIA on SIX.
Where is Idorsia listed?
Idorsia Ltd. is listed on SIX. Our directory also records these other listings: BX:19T; DUS:19T; FWB:19T; GETTEX:19T; HAM:19T; HAN:19T; LS:A2DTEB; LSIN:0RQE; LSX:A2DTEB; MUN:19T; SWB:19T; TRADEGATE:19T; XETR:19T.
Which country or territory is Idorsia listed under?
Our directory records Idorsia Ltd. under Switzerland.
What does Idorsia do?
Our directory classifies Idorsia Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Idorsia?
The ISIN recorded for Idorsia Ltd. is CH0363463438.
Does aibio.space cover Idorsia?
aibio.space lists Idorsia Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
What is the latest Idorsia (IDIA) stock news?
Our latest story on Idorsia, dated Jun 9, 2026: "Idorsia takes up to CHF 250 million senior secured term loan". The first CHF 150 million tranche will refinance the existing New Money Facility, of which CHF 105 million has been drawn. Source.
Does Idorsia have debt, a term loan or convertible notes?
Our latest debt story, dated Jun 9, 2026: "Idorsia takes up to CHF 250 million senior secured term loan". The first CHF 150 million tranche will refinance the existing New Money Facility, of which CHF 105 million has been drawn. Source.
Which companies are similar to Idorsia?
Companies in our directory listed in the same country and business area as Idorsia: Curatis Holding, AC Immune SA, Addex Therapeutics, Siegfried Holding, Basilea Pharmaceutica, BeOne Medicines.
How can I follow Idorsia (IDIA) news?
Press Follow on this page to add Idorsia to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Idorsia so far, in Debt Financing.
Investor discussion: Idorsia
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Idorsia Ltd.
- Ticker
- IDIA
- Listing
- SIX
- Country or territory
- Switzerland
- Business scope
- Pharmaceuticals: Major
- ISIN
- CH0363463438
- Other listed symbols
- BX:19T; DUS:19T; FWB:19T; GETTEX:19T; HAM:19T; HAN:19T; LS:A2DTEB; LSIN:0RQE; LSX:A2DTEB; MUN:19T; SWB:19T; TRADEGATE:19T; XETR:19T
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction